moderna

US FDA approves Moderna’s next-generation COVID-19 vaccine for adults 65 or older

US FDA approves Moderna’s next-generation COVID-19 vaccine for adults 65 or older

  • The vaccine has also been approved for people aged 12 to 64 with at least one or more underlying risk factors
  • The Moderna vaccine, branded mNEXSPIKE, can be stored in refrigerators rather than freezers
By Reuters ·

OSZAR »